Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.

MLA

Kambere, Marijo, et al. “Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.” Therapeutic Innovation & Regulatory Science, vol. 58, no. 5, Sept. 2024, pp. 987–95. EBSCOhost, https://doi.org/10.1007/s43441-024-00674-x.

APA

Kambere, M., Vu, H., Kappel, D., Oh, K., Budashewitz, P., & Concato, J. (2024). Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency. Therapeutic Innovation & Regulatory Science, 58(5), 987–995. https://doi.org/10.1007/s43441-024-00674-x

Chicago

Kambere, Marijo, Hong Vu, Dana Kappel, Kukhwa Oh, Philip Budashewitz, and John Concato. 2024. “Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.” Therapeutic Innovation & Regulatory Science 58 (5): 987–95. doi:10.1007/s43441-024-00674-x.